NDC 50090-6393-01 - PIOGLITAZONE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6393
- Requested NDC
- 50090-6393-01
- Package NDCs from labels
- 50090-6393-0, 50090-6393-1, 50090-6393-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2026-01-06 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6393-0 | PIOGLITAZONE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 50090-6393-1 | PIOGLITAZONE HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6393 | PIOGLITAZONE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 2 | Current NDC, 2 package rows | 20230317_29073b0a-1d7e-4354-87c7-e764106978d8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6393-0 | EA - Each | 50090-6393 | 4078a75b-e73d-424a-915f-b4e32f30b8a3 | 1 | 2023-04-07 |
| 50090-6393-1 | EA - Each | 50090-6393 | e8473b58-cec6-426d-9cdf-0d64d8ec3c3d | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 1fa2703e-fb73-44d5-aaa2-b12b1090d42c | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Preferred Pharmaceuticals Inc. | c748f901-8321-4dc2-8848-b7ed27f11f97 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Actoplus Met | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Takeda Pharmaceuticals America, Inc. | 42e49120-6f3f-11db-9fe1-0800200c9a66 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Preferred Pharmaceuticals, Inc. | 164c444c-7c56-4482-9cbd-0e0f0ad30c44 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | ANDA200268 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Preferred Pharmaceuticals, Inc. | 060e3169-46a7-419d-9acc-05586cb2406b | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | ANDA200268 317573 JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | GSMS, Incorporated | d740d2a2-b26d-4b16-aedc-e4b4b1c94daa | 2026-06-19 | Boxed warning, Warnings, Adverse reactions | 312441 312440 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Major Pharmaceuticals | 72b46a1e-d9ea-4a47-95ef-5eae96ef1e7f | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | ANDA200268 312440 317573 JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 6cd7c8b7-f5d4-423b-ae9f-86541869d8cf | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | ANDA200268 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | 466ef4c8-84d4-4ded-8505-a33f12adf31c | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | ANDA200268 312441 JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | e64b46e5-3c94-4635-908e-cdc2263bd3d4 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | ANDA200268 312441 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | fbdaaa34-06c4-49af-85b4-91a85922b30b | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | REMEDYREPACK INC. | 3a9f6777-9b4f-482a-aa4e-4900f9d35b8e | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | ANDA200268 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | REMEDYREPACK INC. | 55f9b2d8-3e78-4e2f-bcf1-d00595078fa1 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | ANDA200268 312440 JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 41a9586c-8768-4fc3-bb78-e6d98b09030b | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | ANDA200268 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | AvKARE | 22569835-bc9f-7787-e063-6394a90a6232 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 312441 312440 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | American Health Packaging | f3a2222d-5156-4533-bb4b-74652c8eb9c7 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 312440 317573 JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 29073b0a-1d7e-4354-87c7-e764106978d8 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | ANDA200268 50090-6393-1 50090-6393-0 50090-6393 50090639301 312440 7bd7e748-e0f3-491e-845c-e1ad44613642 29073b0a-1d7e-4354-87c7-e764106978d8 JQT35NPK6C |
| pioglitazone and glimepiride | PIOGLITAZONE AND GLIMEPIRIDE | Prasco Laboratories | ea385b3d-cb4c-4550-97b0-93a86533f6dc | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone and metformin hydrochloride | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 86ca843a-441b-488d-be1d-2576aeee19cf | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.